These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 32584821)
21. Factors associated with viral non-suppression among adolescents living with HIV in Cambodia: a cross-sectional study. Chhim K; Mburu G; Tuot S; Sopha R; Khol V; Chhoun P; Yi S AIDS Res Ther; 2018 Nov; 15(1):20. PubMed ID: 30445984 [TBL] [Abstract][Full Text] [Related]
22. Progress Toward the 90-90-90 HIV Targets in Zimbabwe and Identifying Those Left Behind. Hakim AJ; Tippett Barr BA; Kinchen S; Musuka G; Manjengwa J; Munyati S; Gwanzura L; Mugurungi O; Ncube G; Saito S; Parekh BS; Patel H; Duong YT; Gonese E; Sleeman K; Ruangtragool L; Justman J; Herman-Roloff A; Radin E J Acquir Immune Defic Syndr; 2021 Nov; 88(3):272-281. PubMed ID: 34321414 [TBL] [Abstract][Full Text] [Related]
23. Virologic response of treatment experienced HIV-infected Ugandan children and adolescents on NNRTI based first-line regimen, previously monitored without viral load. Kibalama Ssemambo P; Nalubega-Mboowa MG; Owora A; Serunjogi R; Kironde S; Nakabuye S; Ssozi F; Nannyonga M; Musoke P; Barlow-Mosha L BMC Pediatr; 2021 Mar; 21(1):139. PubMed ID: 33752636 [TBL] [Abstract][Full Text] [Related]
24. Trends in viral load suppression among HIV patients on antiretroviral therapy (ART) at Asante Mampong Municipal Hospital, Ghana: 2019-2023. Kyere GA; Vechey GA; Charles-Unadike VO; Tarkang EE BMC Infect Dis; 2024 Oct; 24(1):1170. PubMed ID: 39415134 [TBL] [Abstract][Full Text] [Related]
25. Socioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression. Siefried KJ; Mao L; Kerr S; Cysique LA; Gates TM; McAllister J; Maynard A; de Wit J; Carr A; PLoS One; 2017; 12(4):e0174613. PubMed ID: 28369066 [TBL] [Abstract][Full Text] [Related]
26. Misdiagnosis of HIV treatment failure based on clinical and immunological criteria in Eastern and Central Kenya. Joram SL; Paul G; Moses K; Stanley B; Isaac M; Allan G; Tom M; Lilian K; Mildred M BMC Infect Dis; 2017 Jun; 17(1):383. PubMed ID: 28577527 [TBL] [Abstract][Full Text] [Related]
27. High Coverage of Antiretroviral Treatment With Annual Home-Based HIV Testing, Follow-up Linkage Services, and Implementation of Test and Start: Findings From the Chókwè Health Demographic Surveillance System, Mozambique, 2014-2019. Pathmanathan I; Nelson R; de Louvado A; Thompson R; Pals S; Casavant I; Cardoso MJA; Ujamaa D; Bonzela J; Mikusova S; Chivurre V; Tamele S; Sleeman K; Zhang G; Zeh C; Dobbs T; Vubil A; Auld A; Briggs-Hagen M; Vergara A; Couto A; MacKellar D J Acquir Immune Defic Syndr; 2021 Apr; 86(4):e97-e105. PubMed ID: 33252546 [TBL] [Abstract][Full Text] [Related]
28. Adherence to viral load testing guidelines, barriers, and associated factors among persons living with HIV on ART in Southwestern Uganda: a mixed-methods study. Lubega P; Nalugya SJ; Kimuli AN; Twinokusiima M; Khasalamwa M; Kyomugisa R; Kabami J; Owaraganise A BMC Public Health; 2022 Jun; 22(1):1268. PubMed ID: 35768800 [TBL] [Abstract][Full Text] [Related]
29. Routine viral load monitoring and enhanced adherence counselling at a public ART centre in Mumbai, India. Laxmeshwar C; Acharya S; Das M; Keskar P; Pazare A; Ingole N; Mehta P; Gori P; Mansoor H; Kalon S; Singh P; Mathur T; Ferlazzo G; Isaakidis P PLoS One; 2020; 15(5):e0232576. PubMed ID: 32369504 [TBL] [Abstract][Full Text] [Related]
30. High viral suppression and low attrition in healthy HIV-infected patients initiated on ART with CD4 above 500 cells/µL in a program setting in Uganda. Byonanebye DM; Semitala FC; Katende J; Bakenga A; Arinaitwe I; Kyambadde P; Musinguzi P; Biraro IA; Byakika-Kibwika P; Kamya MR Afr Health Sci; 2020 Mar; 20(1):132-141. PubMed ID: 33402901 [TBL] [Abstract][Full Text] [Related]
31. Virological failure and treatment switch after ART initiation among people living with HIV with and without routine viral load monitoring in Asia. Teeraananchai S; Law M; Boettiger D; Mata N; Gupte N; Chan YL; Pham TN; Chaiwarith R; Ly PS; Chan YJ; Kiertiburanakul S; Khusuwan S; Zhang F; Yunihastuti E; Kumarasamy N; Pujari S; Azwa I; Somia IKA; Tanuma J; Ditangco R; Choi JY; Ng OT; Do CD; Gani Y; Ross J; Jiamsakul A; J Int AIDS Soc; 2022 Aug; 25(8):e25989. PubMed ID: 36028921 [TBL] [Abstract][Full Text] [Related]
32. Risk factors for delayed viral suppression on first-line antiretroviral therapy among persons living with HIV in Haiti, 2013-2017. Rich SN; Cook RL; Yaghjyan L; Francois K; Puttkammer N; Robin E; Bae J; Joseph N; Pessoa-Brandão L; Delcher C PLoS One; 2020; 15(10):e0240817. PubMed ID: 33119631 [TBL] [Abstract][Full Text] [Related]
33. Determinants of viral load non-suppression among adolescents in Mbale District, Eastern Rural Uganda. Maena J; Banke-Thomas A; Mukiza N; Kuteesa CN; Kakumba RM; Kataike H; Kizito S; Babirye JA; Nakalega R AIDS Res Ther; 2021 Dec; 18(1):91. PubMed ID: 34863196 [TBL] [Abstract][Full Text] [Related]
34. Towards achieving the 90-90-90 HIV targets: results from the south African 2017 national HIV survey. Marinda E; Simbayi L; Zuma K; Zungu N; Moyo S; Kondlo L; Jooste S; Nadol P; Igumbor E; Dietrich C; Briggs-Hagen M BMC Public Health; 2020 Sep; 20(1):1375. PubMed ID: 32907565 [TBL] [Abstract][Full Text] [Related]
35. HIV suppression was maintained during the COVID-19 pandemic in Malawi: a program-level cohort study. Kalua T; Egger M; Jahn A; Chimpandule T; Kolola R; Anderegg N J Clin Epidemiol; 2022 Oct; 150():116-125. PubMed ID: 35788400 [TBL] [Abstract][Full Text] [Related]
36. HIV virological non-suppression and its associated factors in children on antiretroviral therapy at a major treatment centre in Southern Ghana: a cross-sectional study. Afrane AKA; Goka BQ; Renner L; Yawson AE; Alhassan Y; Owiafe SN; Agyeman S; Sagoe KWC; Kwara A BMC Infect Dis; 2021 Aug; 21(1):731. PubMed ID: 34340689 [TBL] [Abstract][Full Text] [Related]
37. Self-rated health among people living with HIV in Spain in 2019: a cross-sectional study. Ruiz-Algueró M; Hernando V; Marcos H; Gutiérrez G; Pérez-Elías MJ; López-Bernaldo de Quirós JC; Pulido F; Górgolas M; Sanz J; Suarez-García I; Fernandez MT; Losa JE; Pérez JL; Ladrero MO; Prieto MÁ; González G; Izquierdo A; Viloria LJ; López I; Martínez E; Castrillejo D; Aranguren R; Belmonte MA; Aranda-García IV; Arraiza A; Diaz A; BMC Infect Dis; 2021 Jan; 21(1):129. PubMed ID: 33516173 [TBL] [Abstract][Full Text] [Related]
38. [Study on the relationship between HIV drug resistance and CD4(+)T cell counts among antiretroviral therapy patients with low viral load]. Liu PT; Xing H; Liao LJ; Leng XB; Wang J; Kan W; Yan J; Zuo ZB; Ruan YH; Shao YM Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Mar; 52(3):277-281. PubMed ID: 29973007 [No Abstract] [Full Text] [Related]
39. Sustained virological response and drug resistance among female sex workers living with HIV on antiretroviral therapy in Kampala, Uganda: a cross-sectional study. Namale G; Kamacooko O; Bagiire D; Mayanja Y; Abaasa A; Kilembe W; Price M; Ssemwanga D; Lunkuse S; Nanyonjo M; Ssenyonga W; Mayaud P; Newton R; Kaleebu P; Seeley J Sex Transm Infect; 2019 Sep; 95(6):405-411. PubMed ID: 31266818 [TBL] [Abstract][Full Text] [Related]
40. HIV viral load suppression among people with mental disorders at two urban HIV clinics in Uganda: a parallel convergent mixed methods study using the social ecological model. Ndagire R; Wangi RN; Ojiambo KO; Nangendo J; Nakku J; Muyinda H; Semitala FC AIDS Res Ther; 2023 Sep; 20(1):68. PubMed ID: 37726822 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]